WALTHAM, Mass. & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Echosens North America, a high-technology company offering the FibroScan ® portfolio of solutions, and ChronWell, a digital health and ...
Echosens today announced that BlueCross BlueShield of Tennessee (BCBSTN) has revised its medical policy governing noninvasive imaging for chronic liver disease, effective July 31, 2026.
PARIS--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, announces the launch of FibroScan 630 Expert, a high-performance elastography engine that ...
BALTIMORE (KFSN) -- Thirty million Americans, or one in 10, have some form of liver disease. It could be scarring from a hepatitis C infection, cirrhosis or even liver cancer. Doctors are now using a ...
The National Institute for Health and Health and Care Excellence (NICE) has recommended FibroScan, a non-invasive hepatic ultrasound scan, as an option for assessing liver damage from fibrosis and ...
This article is brought to you by Our Lady of the Angels. An innovative non-invasive technology at Our Lady of the Angels is helping doctors better detect liver problems, leading to earlier treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results